Literature DB >> 15885581

An introduction to dietary/supplemental omega-3 fatty acids for general health and prevention: part I.

Mark A Moyad1.   

Abstract

The correction of a subtle nutritional deficiency that may reduce the risk of a future chronic disease is indeed a challenge. However, some specific examples in the past, such as the addition of folic acid to prevent neural tube defects and calcium and vitamin D to prevent osteoporosis, should provide some encouragement that some conditions can be prevented with the appropriate addition of a deficient compound. One of the most intriguing current and future impacts on public health may come from a greater intake of omega-3 fatty acids such as alpha-linolenic acid (ALA), eicosapentaenoic acid (EPA), and docosahexaenoic acid (DHA). The omega-3 fatty acids continue to accumulate research that suggests that may prevent a variety of diverse chronic diseases and potentially some acute clinical scenarios. In Part 1 of this manuscript the potential for these compounds to prevent certain cardiovascular conditions are discussed. In Part 2 the potential for an impact in arthritis, numerous areas of cancer research, depression, maternal and child health, neurological diseases, osteoporosis, and other medical disciplines are also briefly covered. The future appears bright for these agents, but specifically which conditions, who qualifies, testing, frequency, adequate sources, future trials and numerous other questions need to be addressed and answered before the potential impact can catch up to the recent hype.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15885581     DOI: 10.1016/j.urolonc.2005.01.016

Source DB:  PubMed          Journal:  Urol Oncol        ISSN: 1078-1439            Impact factor:   3.498


  6 in total

1.  Effects of storage time and added antioxidant on fatty acid composition of red blood cells at -20 degrees C.

Authors:  Anna R Magnusardottir; Gudrun V Skuladottir
Journal:  Lipids       Date:  2006-04       Impact factor: 1.880

2.  Cod liver oil: a potential protective supplement for human glaucoma.

Authors:  Wen-Bin Huang; Qian Fan; Xiu-Lan Zhang
Journal:  Int J Ophthalmol       Date:  2011-12-18       Impact factor: 1.779

3.  Regulation of polyisoprenylated methylated protein methyl esterase by polyunsaturated fatty acids and prostaglandins.

Authors:  Felix Amissah; Shalina Taylor; Randolph Duverna; Lambert T Ayuk-Takem; Nazarius S Lamango
Journal:  Eur J Lipid Sci Technol       Date:  2011-11       Impact factor: 2.679

4.  Plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial.

Authors:  Theodore M Brasky; Amy K Darke; Xiaoling Song; Catherine M Tangen; Phyllis J Goodman; Ian M Thompson; Frank L Meyskens; Gary E Goodman; Lori M Minasian; Howard L Parnes; Eric A Klein; Alan R Kristal
Journal:  J Natl Cancer Inst       Date:  2013-07-10       Impact factor: 13.506

5.  Polyisoprenylated methylated protein methyl esterase overexpression and hyperactivity promotes lung cancer progression.

Authors:  Felix Amissah; Randolph Duverna; Byron J Aguilar; Rosemary A Poku; Gebre-Egziabher Kiros; Nazarius S Lamango
Journal:  Am J Cancer Res       Date:  2014-03-01       Impact factor: 6.166

6.  Clinical trial: marine lipid suppositories as laxatives.

Authors:  Orri Thor Ormarsson; Thormodur Geirsson; Einar Stefan Bjornsson; Tomas Jonsson; Pall Hegli Moller; Thorsteinn Loftsson; Einar Stefansson
Journal:  Mar Drugs       Date:  2012-09-20       Impact factor: 6.085

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.